Company: PCAP
Filing Date: 2025-05-13
Form Type: S-1/A
Source: 0001213900-25-042690
Chunk: 153

Company: ProCap Acquisition Corp
Filing Date: 2025-05-13
Form: S-1/A
Chunk 153
---
)Expenses applied against gross proceeds include offering expenses of approximately $725,000 and underwriting commissions of $0.01 per unit (including any units sold pursuant to the underwriters’ option to purchase additional units), or $2,000,000 in the aggregate, payable to the underwriters (excluding deferred underwriting commissions). See “Use of Proceeds.” (2)Upon the consummation of our initial business combination, the deferred underwriting commissions would be paid as follows: $0.01 per unit on all units sold including those sold pursuant to the underwriters’ option to purchase additional units, or $2.0 million in the aggregate payable to the underwriters for deferred underwriting commissions. See also “Underwriting” for a description of compensation and other items of value payable to the underwriters. (3)If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, initial shareholders, directors, executive officers or their affiliates may purchase shares or public warrants in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See “Proposed Business — Effecting Our Initial Business Combination — Permitted Purchases of Our Securities.”

98

CAPITALIZATION The following table sets forth our capitalization at January 10, 2025, and as adjusted to give effect to the filing of our amended and restated memorandum and articles of association, the sale of our units in this offering and the sale of the private placement units and the application of the estimated net proceeds derived from the sale of such securities, assuming no exercise by the underwriters of their over -allotmentoption:

|                                                                                                                                                                           |     | January 10, 2025 |         |   |     |             |             |   |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-----------------|--------:|:--|:----|:------------|------------:|:--|
|                                                                                                                                                                           |     | Actual           |         |   |     | As Adjusted |             |   |
| Notes payable to related party(1)                                                                                                                                         |     | $                |  10,420 |   |     | $